ResMed | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Ansell USD 326.2M 27.6M 2024-06
AtriCure USD 92.62M 5.83M 2024-12
Baxter International USD 1.02B 19M 2024-12
Cochlear AUD 867.2M 38.9M 2024-06
Cooper Companies USD 660.2M 17.5M 2025-01
CSL USD 3.34B 991M 2024-06
Dexcom USD 709.3M 115.5M 2024-12
Edwards Lifesciences USD 1.09B 2.1M 2024-12
Fisher Paykel Healthcare NZD 588.7M 30.4M 2024-09
Globus Medical USD 393.86M 38.67M 2024-12
Haemonetics USD 196.57M 5.37M 2024-12
Hologic USD 580.5M 22.8M 2024-12
Idexx Laboratories USD 570.66M 25.38M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.64B 268.3M 2024-12
Masimo USD 244.7M 18.5M 2024-12
Medtronic USD 5.52B 49M 2025-01
Philips EUR 1.96B 43M 2024-12
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 751.28M 34.06M 2024-12
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Steris USD 610.33M 31.54M 2024-12
Teleflex USD 439.92M 9.74M 2024-12
Thermo Fisher Scientific USD 4.82B 494M 2024-12



ResMed Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.